Get all your news in one place.
100’s of premium titles.
One app.
Start reading
The Hindu
The Hindu
National
Staff Reporter

COVID-19 | Four-month-old baby dies in Kerala’s Malappuram district

Photo for representational purposes only.

A four-month-old girl baby from Manjeri in Malappuram district, who was under treatment at the Government College Hospital, Kozhikode, died of COVID-19 on Friday.

State Helpline numbers | State-wise tracker | A map of confirmed cases in India

It is learnt that the body fluid samples of her parents have been sent for lab tests and the doctors who attended to her have been asked to go on quarantine. Efforts to trace the source of infection are on.

According to a medical bulletin from the Institute of Maternal and Child Health (IMCH), a wing of the medical college hospital, the baby with a history of congenital heart disease was admitted on April 21 from a private hospital in Malappuram. She was admitted to the private hospital on April 18 with symptoms of pneumonia. She was referred to the IMCH after she developed “seizure and poor sensorium”.

Data | Kerala flattens the coronavirus curve but must remain vigilant as 'import' cases still dominate

Though she had no history of contact with any high risk or low risk category of COVID-19 patients or any epidemiological link, she was admitted to the special intensive care unit as she had severe acute respiratory infection. Her throat swab samples were sent for lab tests and they tested positive for SARS-CoV-2. Despite administering antibiotics for pneumonia and giving ventilator support, she continued to be in shock and developed respiratory failure. She had a cardiac arrest and died on Friday morning.

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.